GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Total Liabilities

PharmX Technologies (ASX:PHX) Total Liabilities : A$1.82 Mil (As of Dec. 2024)


View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Total Liabilities?

PharmX Technologies's Total Liabilities for the quarter that ended in Dec. 2024 was A$1.82 Mil.

PharmX Technologies's quarterly Total Liabilities increased from Dec. 2023 (A$13.57 Mil) to Jun. 2024 (A$13.89 Mil) but then declined from Jun. 2024 (A$13.89 Mil) to Dec. 2024 (A$1.82 Mil).

PharmX Technologies's annual Total Liabilities increased from Jun. 2022 (A$7.57 Mil) to Jun. 2023 (A$14.31 Mil) but then declined from Jun. 2023 (A$14.31 Mil) to Jun. 2024 (A$13.89 Mil).


PharmX Technologies Total Liabilities Historical Data

The historical data trend for PharmX Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Total Liabilities Chart

PharmX Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.98 8.42 7.57 14.31 13.89

PharmX Technologies Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.70 14.31 13.57 13.89 1.82

PharmX Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PharmX Technologies's Total Liabilities for the fiscal year that ended in Jun. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=11.95+(0.133+0.0050000000000004
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.872+0.042+0.883)
=13.89

Total Liabilities=Total Assets (A: Jun. 2024 )-Total Equity (A: Jun. 2024 )
=29.857-15.972
=13.89

PharmX Technologies's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.059+(0.075+0.069
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.615+0+0.883)
=1.82

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=17.969-16.151
=1.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmX Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmX Technologies Business Description

Traded in Other Exchanges
N/A
Address
17 Castlereagh Street, Suite 11.02, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.